doi: 10.1152/ajpendo.1985.249.6.E603 177 HaunerHGlattingGKaminskaDPfeifferEF
By activating the GLP-1 and GIP receptors, it helps regulate insulin secretion and promotes a feeling of satiety in biological models
They found that at the highest dosage of 4.8 mg survodutide weekly, study participants lost 14.9% of their body weight in comparison with a placebo group (2.8% weight loss) [122]
The Role of Lifestyle Integration While tirzepatide is highly effective, it is not a standalone solution
If the predicted growth of GLP-1 users holds true, even a single percentage point increase in produce consumption translates to billions of additional dollars flowing into the industry
Designed as a triple agonist, Retatrutide targets GLP-1, GIP, and glucagon receptorseach playing a pivotal role in weight management, energy regulation, and glucose metabolism